AFNAS
MYGN icon

American Financial Network Advisory Services’s Myriad Genetics MYGN Stock Holding History

American Financial Network Advisory Services’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-77
Closed -$3K – 726
2017
Q3 		$3K Buy
+77
New +$2.2K ﹤0.01% 662

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

American Financial Network Advisory Services's MYGN Position: Q4 2017 in Review

American Financial Network Advisory Services sold out of Myriad Genetics (MYGN) in Q4 2017, closing a stake of 77 shares — an estimated $3K sold.

American Financial Network Advisory Services first reported a position in MYGN in Q3 2017 and held it in 1 quarter. The position peaked at $3K in Q3 2017. 250 funds tracked by Wall St. Rank hold MYGN as of Q4 2017.

  • American Financial Network Advisory Services reported no remaining Myriad Genetics position as of Q4 2017 after selling out during the quarter.
  • American Financial Network Advisory Services sold 77 Myriad Genetics shares in Q4 2017, an estimated $3K.
  • American Financial Network Advisory Services first reported a position in Myriad Genetics in Q3 2017 and held it in 1 quarter.
  • American Financial Network Advisory Services's Myriad Genetics position peaked at $3K in Q3 2017.
  • 250 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2017.

Based on American Financial Network Advisory Services's 13F filing for Q4 2017, filed 2 Jan 2018.